CYFRA 21-1 External Quality Assessment

The RIQAS CYFRA 21-1 EQA programme is designed to cover the analysis of CYFRA21-1 in clinical laboratories when monitoring the response to treatment of cancers such as non-small cell lung carcinoma, cervical, breast and bladder cancer.

  • Lyophilised samples
  • Monthly reporting
  • Testing covers the full range of clinically relevant decision levels
  • Submit results and view reports online via
  • 12 month subscription

Not accredited to ISO/IEC 17043

Downloads Enrolment Document Method Questionnaire Instrument & Reagent Codes
  Cat.No.1 Cat.No.2 Cat.No.3 Cat.No.4
Cat.No. RQ9175 - - -
  1 Parameters - - -
Kit Size 12 x 1 ml
Frequency Monthly Cycle Start March
Parameters CYFRA 21-1 (Cytokeratin 19)    

Make an Enquiry

If you would like further information please submit your enquiry.